These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

304 related items for PubMed ID: 23257423

  • 1. [Detection and clinical significance of FLT3-ITD gene mutation in patients with acute myeloid leukemia].
    Xu YY, Gao L, Ding Y, Sun JZ, Wang N, Wang LL, Yu L.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Dec; 20(6):1312-5. PubMed ID: 23257423
    [Abstract] [Full Text] [Related]

  • 2. [Detection of NPM1, FLT3 and C-KIT mutations in acute myeloid leukemia and their prognostic analysis].
    Li L, Lyu XD, Mi RH, Ding J, Chen L, Wang Q, Yin QS, Hu JY, Fan RH, Wei XD.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Jun; 21(3):601-6. PubMed ID: 23815906
    [Abstract] [Full Text] [Related]

  • 3. [FMS-like tyrosine kinase 3 gene mutations in acute myeloid leukemia].
    Han YL, Zhang SJ, Qiao C, Dai D, Sun XM, Xu YL, Qian SX, Xu W, Wang JS, Li JY.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Oct; 17(5):1135-9. PubMed ID: 19840437
    [Abstract] [Full Text] [Related]

  • 4. CD34 expression predicts an adverse outcome in patients with NPM1-positive acute myeloid leukemia.
    Dang H, Chen Y, Kamel-Reid S, Brandwein J, Chang H.
    Hum Pathol; 2013 Oct; 44(10):2038-46. PubMed ID: 23701943
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Correlation of NPM1, FLT3-ITD mutations with leukocyte count and myeloblasts percentage in AML patients with normal karyotype].
    Su L, Li W, Cui JW, Tan YH, Yang Y, Liu XL, Yu P, Hu RP, Wang LL, Gao SJ.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Jun; 21(3):571-5. PubMed ID: 23815900
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Clinical characteristics of newly diagnosed acute myeloid leukemia patients with NPM1 mutation].
    Wei H, Zhang YQ, Lin D, Wang Y, Zhou CL, Liu BC, Li W, Rao Q, Wang M, Mi YC, Wang JX.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Feb; 22(1):11-5. PubMed ID: 24598642
    [Abstract] [Full Text] [Related]

  • 9. Prognostic implications of NPM1 mutations and FLT3 internal tandem duplications in Egyptian patients with cytogenetically normal acute myeloid leukemia.
    Shamaa S, Laimon N, Aladle DA, Azmy E, Elghannam DM, Salem DA, Taalab MM.
    Hematology; 2014 Jan; 19(1):22-30. PubMed ID: 23540998
    [Abstract] [Full Text] [Related]

  • 10. [Correlation of FLT3 gene expression level and internal tandem duplication mutation in acute myeloid leukemia and its clinical significance].
    Wang YG, Liu XH, Liang Y, Jin J.
    Zhonghua Xue Ye Xue Za Zhi; 2008 Nov; 29(11):741-5. PubMed ID: 19176010
    [Abstract] [Full Text] [Related]

  • 11. [FLT3 Gene Mutations in Acute Myeloid Leukemia].
    Ye L, Ji MM, Sun ZM.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Apr; 23(2):322-7. PubMed ID: 25948179
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Frequency of FLT3 Internal Tandem Duplications in Adult Syrian Patients with Acute Myeloid Leukemia and Normal Karyotype.
    Al-Arbeed IF, Wafa A, Moassass F, Al-Halabi B, Al-Achkar W, Abou-Khamis I.
    Asian Pac J Cancer Prev; 2021 Oct 01; 22(10):3245-3251. PubMed ID: 34711001
    [Abstract] [Full Text] [Related]

  • 14. [Clinical significance of FLT3 internal tandem duplication in acute myeloid leukemia with chromosome abnormality].
    Wang J, Li S, Wang T.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Aug 01; 15(4):700-4. PubMed ID: 17708786
    [Abstract] [Full Text] [Related]

  • 15. [A study of NPM1 and FLT3 gene mutations in acute myeloid leukemia].
    Wu DP, Yan LZ, Yang L, Chen SN, Wu XJ, Liang JY.
    Zhonghua Nei Ke Za Zhi; 2007 Nov 01; 46(11):907-10. PubMed ID: 18261272
    [Abstract] [Full Text] [Related]

  • 16. FLT3 internal tandem duplication and FLT3-D835 mutation in 80 AML patients categorized into cytogenetic risk groups.
    Mały E, Przyborsk M, Nowak T, Nowak J, Januszkiewicz D.
    Postepy Hig Med Dosw (Online); 2010 Oct 18; 64():466-70. PubMed ID: 20966504
    [Abstract] [Full Text] [Related]

  • 17. [Flt-3/ITD mutation in pediatric leukemia and its clinical significance].
    Wang J, Wang T, Li S, Lin L, Gang Y.
    Ai Zheng; 2007 Jan 18; 26(1):58-63. PubMed ID: 17222369
    [Abstract] [Full Text] [Related]

  • 18. Age-dependent frequencies of NPM1 mutations and FLT3-ITD in patients with normal karyotype AML (NK-AML).
    Schneider F, Hoster E, Schneider S, Dufour A, Benthaus T, Kakadia PM, Bohlander SK, Braess J, Heinecke A, Sauerland MC, Berdel WE, Buechner T, Woermann BJ, Feuring-Buske M, Buske C, Creutzig U, Thiede C, Zwaan MC, van den Heuvel-Eibrink MM, Reinhardt D, Hiddemann W, Spiekermann K.
    Ann Hematol; 2012 Jan 18; 91(1):9-18. PubMed ID: 21744003
    [Abstract] [Full Text] [Related]

  • 19. Aberrant expression of CD7 in myeloblasts is highly associated with de novo acute myeloid leukemias with FLT3/ITD mutation.
    Rausei-Mills V, Chang KL, Gaal KK, Weiss LM, Huang Q.
    Am J Clin Pathol; 2008 Apr 18; 129(4):624-9. PubMed ID: 18343790
    [Abstract] [Full Text] [Related]

  • 20. BCRP mRNA and FLT3-ITD are independent poor risk factors in adult patients with acute myeloid leukemia and intermediate or normal karyotype.
    Nasiłowska-Adamska B, Warzocha K, Solarska I, Borg K, Pieńkowska-Grela B, Czyż A.
    Eur J Haematol; 2017 Sep 18; 99(3):255-261. PubMed ID: 28618074
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.